Ascendis Pharma A/S
ASND- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001612042
In the last 90 days, Ascendis Pharma A/S insiders filed 1 open-market purchase and 2 sales; 313 institutions reported holding it in 13F filings for Q2 2026, worth $17.8B in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Ascendis Pharma A/S changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 171 | 166 | −5 |
| Shares | 55.0M | 58.0M | +2.96M (+5.4%) |
| Value | $7.24B | $9.24B | +$2.01B (+27.7%) |
New holders (27)
Institutions that held Ascendis Pharma A/S at the end of Q3 2021 but not at the end of Q2 2021.
Sold out (32)
Institutions that held Ascendis Pharma A/S at the end of Q2 2021 and filed for Q3 2021 without it.